Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 405
Titolo Data di pubblicazione Autore(i) File
Acute myeloid leukemia in the elderly: results obtained with conventional chemotherapy 1-gen-2000 Visani, G; Piccaluga, Pp; Isidori, A; Malagola, Michele; Grafone, T; Tura, S.
No preferential sensitivity of t(8;21) acute myeloid leukemia cells to cytosine arabinoside in vitro 1-gen-2000 Grafone, T; Visani, G; Piccaluga, Pp; Isidori, A; Tosi, P; Malagola, Michele; Ottaviani, E; Testoni, N; Tura, S.
Alpha-interferon as an alternative to allogeneic bone marrow transplantation in the treatment of positive adult acute lymphoblastic leukemia. 1-gen-2000 Isidori, A; Visani, G; Martinelli, G; Piccaluga, Pp; Tosi, P; Amabile, M; Pastano, R; Malagola, Michele; Cavo, M; Tura, S.
High TRM in allogeneic bone marrow transplantation (BMT) from VUD in primary refractory/relapsed acute leukaemia patients 1-gen-2000 Piccaluga, Pp; Bandini, G; Visani, G; Stanzani, M; Isidori, A; Malagola, Michele; Falcioni, S; Mianulli, Am; Pastano, R; Tura, S.
Complete remission before allo-transplantation is crucial for improving survival of acute phase chronic myeloid leukemia 1-gen-2000 Visani, G; Rosti, G; Bandini, G; Stanzani, M; Tosi, P; Malagola, Michele; Isidori, A; Martinelli, G; Piccaluga, Pp; Testoni, N; Tura, T.
Antiangiogenic therapy with thalidomide improves anemia, thrombocytopenia, hyperleucocytosis, splenomegaly in idiopathic myelofibrosis. 1-gen-2000 Piccaluga, Pp; Finelli, C; Ricci, P; Cavo, M; Pileri, Sa; Isidori, A; Malagola, Michele; Grafone, T; Tura, S; Visani, G.
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukemia. 1-gen-2000 Piccaluga, Pp; Visani, G; Rosti, G; Bandini, G; Tosi, P; Isidori, A; Malagola, Michele; Stanzani, M; Martinelli, G; Testoni, N; Ricci, P; Tura, S.
Chemotherapy of secondary leukemias 1-gen-2000 Visani, G; Pagano, L; Pulsoni, A; Tosi, P; Dizdari, A; Piccaluga, Pp; Pastano, R; Malagola, Michele; Isidori, A; Grafone, T; Tura, S.
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia. 1-gen-2000 Visani, G; Rosti, G; Bandini, G; Tosi, P; Isidori, A; Malagola, Michele; Stanzani, M; Martinelli, G; Piccaluga, P; Testoni, N; Ricci, P; Tura, S.
Double reinforcement with fludarabine/high dose cytarabine enanches the impact of autologous stem cell transplantation in acute myeloid leukemia patients. 1-gen-2001 Visani, G; Lemoli, Rm; Isidori, A; Piccaluga, Pp; Martinelli, G; Gugliotta, L; Bonini, A; Malagola, Michele; Motta, Mr; Rizzi, S; Castellani, S; Tura, S.
Pulsed ATRA as single therapy restores long term remission in PML-RARa positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. 1-gen-2001 Visani, G; Isidori, A; Malagola, Michele; Buonamici, S; Ottaviani, E; Martinelli, G.
Quantitative Rt-PCR in P-190bcrABL+ acute lymphoblastic leukemia: alpha-interferon after autologous-SCT reduces minimal residual disease allowing long term remission 1-gen-2001 Visani, G; Martinelli, G; Amabile, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Pane, F; Ottaviani, E; Cavo, M; Testoni, N; Tura, S.
Efficacy of Glivec /STI571 in conjunction with alpha-interferon in a case of relapsed p190 BCR-ABL positive acute lymphoblastic leukemia. 1-gen-2001 Visani, G; Isidori, A; Malagola, Michele; Alberti, D; Piccaluga, Pp; Martinelli, G; Amabile, M; Grafone, T; Delfini, C; Tura, S; Baccarani, M.
Rare CBFbeta-MYH11 fusion transcripts in patients with acute myeloid leukemia associated with inversion of chromosome 16. 1-gen-2001 Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Terragna, C; Amabile, M; Giannini, B; Soverini, S; Zardini, C; Visani, G; Isidori, A; Malagola, Michele; Ruggeri, D; Piccaluga, Pp; Baccarani, M; Tura, S.
Single Center experience of detection of minimal residual disease in patients with AML1/ETO associated acute myeloid leukemia by RT-PCR. 1-gen-2001 Buonamici, S; Ottaviani, E; Testoni, N; Terragna, C; Amabile, M; Giannini, B; Soverini, S; Ruggeri, D; Luatti, S; Zardini, C; Visani, G; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S; Martinelli, G.
Pulsed ATRA as single therapy restores long term remission in molecular positive acute promyelocytic leukemia: real-time quantitation of minimal residual disease 1-gen-2001 Visani, G; Malagola, Michele; Isidori, A; Piccaluga, Pp; Martinelli, G; Buonamici, S; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S.
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients 1-gen-2001 Visani, G; Lemoli, Rm; Isidori, A; Piccaluga, Pp; Martinelli, G; Malagola, Michele; Gugliotta, L; Bonini, A; Bonifazi, F; Motta, Mr; Rizzi, S; Castellani, S; Tura, S.
Efficacy of thalidomide in myelofibrosis with myeloid metaplasia. 1-gen-2001 Piccaluga, Pp; Visani, G; Pileri, Sa; Finelli, C; Ascani, S; Isidori, A; Malagola, Michele; Grafone, T; Baccarani, M; Tura, S.
Liposomal daunorubicin (DAUNOXOME) for treatment of relapsed meningeal acute myeloid leukemia. 1-gen-2001 Piccaluga, Pp; Visani, G; Isidori, A; Malagola, Michele; Pileri, Sa; Baccarani, M; Tura, S.
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia – analysis of 848 patients. 1-gen-2001 Visani, G.; Bernasconi, P.; Boni, M.; Castoldi, G. L.; Ciolli, S.; Clavio, M.; Cox, M. C.; Cuneo, A.; DEL POETA, G.; Dini, D.; Falzetti, D.; Fanin, R.; Gobbi, M.; Isidori, A.; Leoni, F.; Liso, V.; Malagola, Michele; Martinelli, G.; Mecucci, C.; Piccaluga, P. P.; Petti, M. C.; Rondelli, R.; Russo, Domenico; Sessarego, S.; Specchia, G.; Testoni, N.; Torelli, G.; Mandelli, F.; Tura, S. .
Mostrati risultati da 1 a 20 di 405
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile